After Prime Minister Narendra Modi’s review of the coronavirus vaccine in Pune, Adar Poonawala, head of the Serum Institute of India (SII), said the central government could buy 30-40 crore doses by July. Poonawala said PM Modi was already very aware of the vaccine. Poonavala, who gave good news about the corona vaccine, said it would be available to India first.
SAI CEO Adar Poonawala said, “So far, we have not written anything from the Government of India on how many doses they will buy. But there are indications that the government may buy 30-40 crore doses by July 2021.” . Poonawala said the serum agency is in the process of applying for the emergency use of Coveshield over the next two weeks.
After Prime Minister Modi’s visit, Adar Poonawala said the first vaccine would be available in India. After this, Kovacs, mainly in Africa, will be served there. AstraZeneca and Oxford dominate the UK and European markets. Our priority is India and Kovacs. “We have built the largest epidemic level facility in Pune and our new campus in Mandari,” he said. During this visit the Prime Minister was also briefed and detailed discussions were held.
ALSO READ: Which corona vaccine is most effective, who doesn’t get heavy in the pocket? Find out every single piece of information that is important to you
Prime Minister Narendra Modi is understood to have visited Ahmedabad, Hyderabad and Pune on Saturday to review the development work of the coronavirus vaccine. Finally PM Modi visited SII. Modi has visited Modi’s SII to check on the progress of the coronavirus vaccine and its procurement, production and distribution systems.
What did the PMO say after the PM visit?
Following PM Modi’s visit, the Prime Minister’s Office (PMO) aims to gain insight into factors such as challenges, preparedness and roadmap in India’s efforts in the immunization of citizens. At the same time, PM Modi tweeted after his visit to Yd Tidus Park, “Yd Tidus Biotech Park in Ahmedabad and Yd Tidus Cadila have received more information about the DNA vaccine being developed in India. I applaud the team’s efforts in this journey. The government is actively working with them. ”
SII Partnership with Oxford University
The Serum Institute of India has partnered with global cecal company AstraZeneca and the University of Oxford for the corona vaccine. Interim results of a phase III trial of the Covid-19 pandemic vaccine have recently been released. Early indications suggest that the vaccine reduces the spread of the virus in cases of untreated infection. Based on the combined analysis of the two trials, the vaccine is an average of 70% effective. In India, the vaccine is named CovShield.
.
